Allianz Asset Management Gmb H Black Diamond Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.19 - $28.17 $126,836 - $293,108	-10,405 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$22.23 - $34.75 $575,312 - $899,330	-25,880 Reduced 71.32%	10,405 $252,000
Q4 2020 Feb 16, 2021	SELL	$29.47 - $35.0 $432,855 - $514,080	-14,688 Reduced 28.82%	36,285 $1.16 Million
Q3 2020 Nov 13, 2020	BUY	$26.17 - $43.07 $793,186 - $1.31 Million	30,309 Added 146.68%	50,973 $1.54 Million
Q2 2020 Aug 14, 2020	SELL	$22.3 - $44.8 $112,235 - $225,478	-5,033 Reduced 19.59%	20,664 $871,000
Q1 2020 May 14, 2020	BUY	$18.18 - $39.48 $467,171 - $1.01 Million	25,697 New	25,697 $641,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $87.9M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.